Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRFAP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXorf40B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM210A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXO3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on